[ARS] Aptevo Therapeutics Inc SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

07/03/2025 - 04:15 PM

ARS - Aptevo Therapeutics Inc

ARS Filing - Aptevo Therapeutics Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Aptevo Therapeutics Inc (APVO)

Acceptance Date: 2025-07-03T16:15:12.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Aptevo Therapeutics Inc

NASDAQ:APVO

View APVO Stock Overview →

APVO Rankings

#6753 Ranked by Market Cap

N/A Ranked by Dividends

APVO Latest News

Mar 26, 2026

Aptevo Provides State of the Business Report and 2025 Financial Results

Mar 19, 2026

Aptevo to Participate in March 2026 Conferences

Mar 10, 2026

Mipletamig Delivers Compelling 86% Clinical Benefit Rate and No CRS as Evaluable AML Patient Data increases by Nearly 50%

Feb 3, 2026

Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth

Jan 9, 2026

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

APVO Latest SEC Filings

Mar 26, 2026

[10-K] Aptevo Therapeutics Inc. Files Annual Report

Mar 26, 2026

[8-K] Aptevo Therapeutics Inc. Reports Material Event

Mar 10, 2026

[8-K] Aptevo Therapeutics Inc. Reports Material Event

Feb 18, 2026

[8-K] Aptevo Therapeutics Inc. Reports Material Event

Feb 17, 2026

[SCHEDULE 13G/A] Aptevo Therapeutics Inc. Amended Passive Investment Disclosure

APVO Stock Data

Market Cap 4.50M

Float 997.08k

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City SEATTLE